首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1619045

醫藥中間體市場規模、佔有率、成長分析、按產品、按類別、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product, By Category, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年醫藥中間體的全球市場規模為291.8億美元，從2023年的312.5億美元成長到2031年的541億美元，在預測期內（2024-2031年）預計複合年成長率為7.1。

由於醫藥和化妝品行業的需求不斷成長，醫藥中間體市場正在經歷顯著成長，因為這些中間體是活性藥物成分 (API) 生產的重要原料。隨著人們對高科技治療和個人化醫療的日益關注，對 API 的需求不斷增加，刺激了市場擴張。然而，生物製藥相關的高成本以及生產原料藥所需的大量資本投資等挑戰可能會阻礙成長。但隨著新興市場製造技術的發展和研發投入的加大，市場發展的機會也大大拓展。利用高品質的基礎原料，該領域將不斷發展，以滿足製藥和農化製造的多樣化需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

BASF SE（Germany）
Sanofi SA（France）
Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
Dishman Carbogen Amcis Ltd.（India）
Evonik Industries AG（Germany）
Arkema Inc.（France）
Lonza Group AG（Switzerland）
Wuxi AppTec Co., Ltd.（China）
Aurobindo Pharma Limited（India）
Lianhe Chemical Technology Co., Ltd.（China）
Cambrex Corporation（US）
Vertellus Holdings LLC（US）
Hovione LLC（Portugal）
Hikal Ltd.（India）
Codexis Inc.（US）
Aceto Corporation（US）
Interchem Corporation（US）
Midas Pharma GmbH（Germany）
Arbiom（US）

結論和建議

簡介目錄

Product Code: SQMIG35I2111

Global Pharmaceutical Intermediates Market size was valued at USD 29.18 billion in 2022 and is poised to grow from USD 31.25 billion in 2023 to USD 54.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2024-2031).

The pharmaceutical intermediates market is witnessing substantial growth, driven by rising demand in the pharmaceutical and cosmetic sectors as these intermediates serve as essential raw materials in active pharmaceutical ingredient (API) production. With the growing focus on high-tech therapies and personalized medicine, the need for APIs is escalating, further fueling market expansion. However, challenges such as high costs associated with biopharmaceuticals and the significant capital investment required for API production could hinder growth. Nevertheless, advancements in manufacturing technologies and increased investment in research and development are poised to unlock considerable opportunities within the market. By leveraging quality basic materials, the sector is set to continue evolving, catering to the diverse needs of drug and pesticide production.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Intermediates market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Intermediates Market Segmental Analysis

Global Pharmaceutical Intermediates Market is segmented by product, category, application, end user and region. Based on product, the market is segmented into chemical intermediates, bulk drug intermediates, chiral intermediates, achiral intermediates and custom intermediates. Based on category, the market is segmented into branded drug intermediates and generic drug intermediates. Based on application, the market is segmented into analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs, antimicrobial drugs, anti-cancer drugs and others. Based on end user, the market is segmented into biotech and pharma companies, research laboratory and CMOS/CROS. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Intermediates Market

The Global Pharmaceutical Intermediates market is significantly driven by the rising prevalence of chronic diseases and the aging demographic across the globe. The World Health Organization (WHO) notes that the number of diabetes cases soared from 108 million in 1980 to 422 million by 2014, and this upward trend persists. Moreover, WHO projects that chronic diseases will surge by 57% by 2020, revealing that a considerable proportion of the population is affected. These alarming statistics underscore the escalating demand for drug formulations aimed at managing chronic conditions, thereby fueling substantial growth in the Pharmaceutical Intermediates market during the forecast period.

Restraints in the Global Pharmaceutical Intermediates Market

One significant restraint affecting the global pharmaceutical intermediates market is the substantial expense linked to acquiring biopharmaceutical drugs. This high financial burden not only limits accessibility for many companies but also restricts their ability to invest in research and development. Additionally, the considerable capital investment necessary for the production of active pharmaceutical ingredients (APIs) further hinders market growth. These financial challenges can deter new entrants and stifle innovation within the industry, ultimately impacting the overall development and supply chain of pharmaceutical intermediates and creating barriers to fulfilling market demand.

Market Trends of the Global Pharmaceutical Intermediates Market

The Global Pharmaceutical Intermediates market is experiencing significant growth driven by the escalating prevalence of chronic cardiovascular diseases, particularly ischemic heart disease (IHD), which is projected to impact over 126 million individuals worldwide. As IHD emerges as the leading cause of death globally, with forecasts suggesting an alarming increase to 1,845 cases per 100,000 individuals by 2030, the demand for pharmaceutical intermediates essential for the production of cardiovascular medications is surging. This trend accentuates the urgent need for innovation in drug formulation and production, positioning pharmaceutical intermediates as a critical sector in addressing rising healthcare costs associated with heart disease.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis

Global Pharmaceutical Intermediates Market Size by Product & CAGR (2024-2031)

Market Overview
Chemical Intermediates
Bulk Drug Intermediates
Chiral Intermediates
Achiral Intermediates
Custom Intermediates

Global Pharmaceutical Intermediates Market Size by Category & CAGR (2024-2031)

Market Overview
Branded Drug Intermediates
Generic Drug Intermediates

Global Pharmaceutical Intermediates Market Size by Application & CAGR (2024-2031)

Market Overview
Analgesics
Anti-Inflammatory Drug
Cardiovascular Drugs
Anti-Diabetic Drugs
Antimicrobial Drugs
Anti-Cancer Drugs
Others

Global Pharmaceutical Intermediates Market Size by End User & CAGR (2024-2031)

Market Overview
Biotech and Pharma Companies
Research Laboratory
CMOS/CROS

Global Pharmaceutical Intermediates Market Size & CAGR (2024-2031)

North America (Product, Category, Application, End User)
- USA
- Canada
Europe (Product, Category, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Category, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Category, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Category, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dishman Carbogen Amcis Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkema Inc. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lianhe Chemical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertellus Holdings LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hovione LLC (Portugal)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikal Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aceto Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Interchem Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbiom (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments